News | April 11, 2024
Evonik launches Botanicals & Natural Actives business segment
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Company has bought 7.73 million shares for KRW 146.1 billion thus securing the largest shareholder status in Bukwang Pharmaceutical
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
This is Enzene Biosciences third biosimilar to be approved
Subscribe To Our Newsletter & Stay Updated
